Author
Bowtie Team
Updated on
2026-09-05
Lung cancer remains the primary cause of cancer-related mortality in Hong Kong, with its formidable fatality rates causing widespread concern. While certain types and stages of lung cancer can be treated surgically, questions often arise regarding surgical success rates and patient eligibility. In this comprehensive guide, the Bowtie team examines the procedures, eligibility criteria, benefits, and recovery care involved in lung cancer surgery.
Types of Lung Cancer Surgery and Procedures
Thoracic surgeons determine the appropriate surgical approach based primarily on the tumour’s location, size, and the patient’s baseline pulmonary reserve. Lung resection procedures aim to remove malignant tissue whilst preserving as much healthy, functioning lung parenchyma as possible.
The primary surgical operations for lung cancer include:
-
Lobectomy (肺葉切除術): The most widely performed surgical procedure for early-stage non-small cell lung cancer. The human lungs comprise five lobes (three in the right lung and two in the left). When malignant cells are confined to a single anatomical lobe, that entire lobe is resected along with surrounding lymph nodes.
-
Bi-lobectomy (雙肺葉切除術): The surgical excision of two contiguous lobes, performed exclusively on the three-lobed right lung when a tumour spans adjacent lobes.
-
Pneumonectomy (肺切除術): The complete surgical removal of an entire lung, typically indicated when the tumour is centrally situated near the main bronchus or pulmonary hilum.
-
Minimally Invasive Lung Resection (微創肺切除術): Utilising video-assisted thoracic surgery (VATS) or robotic-assisted thoracic surgery (RATS), this method accesses peripheral tumours without significant lymph node swelling through small keyhole incisions.
When lung cancer is diagnosed at a very early stage, or when a patient presents with compromised cardiopulmonary function or a peripheral tumour measuring under 3 cm, sublobar resections are often considered:
-
Segmentectomy (段式切除術): Excision of one or more specific anatomical bronchopulmonary segments within a lobe, sparing surrounding healthy tissue.
-
Wedge Resection (楔形切除術): Removal of a small, non-anatomical wedge-shaped wedge of lung tissue containing the tumour and an intact margin of healthy parenchyma.
How Do Doctors Determine Suitability for Lung Cancer Surgery?
Surgeons assess multiple clinical variables before recommending surgical intervention, including patient age, histological cancer type, tumour growth velocity, anatomical location, pathological stage, tumour dimensions, and cardiopulmonary function.
Lung malignancies fall predominantly into two main histological categories: Small Cell Lung Cancer (SCLC) and Non-Small Cell Lung Cancer (NSCLC). SCLC exhibits aggressive biological behaviour and rapid dissemination, making primary surgery unsuitable for the vast majority of patients, who instead receive systemic treatments like chemotherapy and radiotherapy. In contrast, NSCLC is staged from Stage 1 to Stage 4, with stages further classified into sub-stages A and B:
-
Stage 1A & Stage 1B: Tumours in Stage 1A measure under 3 cm, whilst Stage 1B tumours range from 3 cm to 5 cm. Both are prime candidates for complete curative surgical resection.
-
Stage 2A & Stage 2B: Tumours in Stage 2A can reach up to 7 cm (or smaller with local hilar node spread), whilst Stage 2B tumours are larger than 5 cm or involve adjacent structures and regional lymph nodes. Although local structures may be involved, primary radical resection remains standard where technically feasible.
-
Stage 3A & Stage 3B: In Stage 3, cancer has spread to mediastinal lymph nodes or nearby critical thoracic tissues. Surgery alone cannot achieve cure; multimodality treatment combining neoadjuvant or adjuvant systemic therapies with surgery is generally required.
What Are the Benefits and Success Rates of Lung Cancer Surgery?
Where clinically indicated, surgical resection offers the highest likelihood of cure by completely excising the primary lesion and clearing micro-metastases within regional draining lymph nodes. Contemporary advances in thoracic surgery mean minimally invasive techniques have largely supplanted conventional open thoracotomy, bringing notable clinical benefits.
Because minimally invasive approaches avoid extensive incisions through chest wall musculature and rib spreading, patients experience reduced tissue trauma, smaller surgical scars, accelerated wound healing, and significantly milder postoperative pain, which in turn reduces dependence on opioid painkillers.
Furthermore, retaining chest wall integrity allows baseline respiratory function and physical mobility to recover considerably faster, dramatically reducing hospital stays. Five-year survival rates correlate strongly with pathological cancer stage at diagnosis:
-
Stage 1A: 5-year survival reaches approximately 92%.
-
Stage 2A: 5-year survival is roughly 83%.
-
Stage 3A: 5-year survival is around 77%.
-
Stage 1B (tumours >3 cm without nodal spread): 5-year survival is approximately 68%.
How Does Postoperative Adjuvant Therapy Reduce Lung Cancer Recurrence?
While early-stage lung cancer boasts favourable surgical outcomes, patients still face a non-negligible risk of disease relapse if surgical intervention is not supplemented by appropriate adjuvant therapies.
Clinical studies indicate that approximately 30% to 70% of lung cancer patients experience recurrence within one to two years following primary resection and chemotherapy. When cancer recurs, malignant cells may reappear in adjacent lung tissue (local recurrence), spread to regional lymph nodes (regional recurrence), or metastasise to distant vital organs like the brain, bones, or liver (distant recurrence). Once distant recurrence takes place, the prospects of curative treatment drop substantially.
Consequently, even in early or locally advanced stages, clinical oncologists evaluate each patient’s tumour pathology and relapse risk to determine the suitability of postoperative adjuvant therapies—including chemotherapy, radiotherapy, targeted therapy, or immunotherapy—to consolidate local control and minimise recurrence.
The contemporary standard of care endorsed by international clinical practice guidelines, including the National Comprehensive Cancer Network (NCCN) and the American Society of Clinical Oncology (ASCO), incorporates adjuvant immunotherapy following complete surgery and platinum-based chemotherapy. The specific choice of therapy depends on tumour genomics: patients with actionable driver mutations (such as EGFR mutations or ALK rearrangements) receive adjuvant targeted therapies, whereas those without targetable alterations are evaluated for adjuvant immunotherapy combinations. You should discuss the most suitable approach with your attending clinical oncologist.
Reference Costs for Lung Cancer Surgery in Hong Kong
Surgical expenses for lung cancer treatment in Hong Kong private hospitals vary depending on patient condition, surgical complexity, and chosen operative approach. Different procedures (such as segmentectomy, lobectomy, or pneumonectomy) and advanced techniques (such as VATS or robotic-assisted surgery) carry distinct fee structures covering surgeon fees, anaesthetist charges, operating theatre time, and inpatient care. It is advisable to obtain a formal pre-operative medical expense quotation from your surgeon and verify insurance pre-authorisation beforehand.
Potential Complications and Side Effects of Lung Cancer Surgery
Like all major thoracic procedures, lung cancer surgery involves potential postoperative complications and side effects, which may include:
-
Fatigue and generalised weakness: Post-surgical fatigue is common during early convalescence as the body expends energy healing thoracic tissues.
-
Wound infection: Localised infection around surgical incision sites or chest tube drainage tracts.
-
Pulmonary infections: Pneumonia, atelectasis, or bronchial mucous plugging caused by impaired cough clearance.
-
Breathlessness (Dyspnoea): Shortness of breath during exertion due to the excision of functional lung volume.
-
Chronic neuropathic pain: Persistent intercostal neuralgia or altered sensation along the chest wall incision site.
Postoperative Care and Recovery Tips After Lung Cancer Surgery
Undergoing lung resection is a major physiological stressor. Proper postoperative nursing and lifestyle adjustments are essential to support recovery and preserve respiratory reserve:
-
Attend scheduled medical follow-ups: Assist the patient in attending routine outpatient consultations, and remain alert to emergent symptoms such as high fever, sudden shortness of breath, haemoptysis, or wound redness that necessitate immediate medical review.
-
Promote early ambulation: Encourage the patient to get out of bed and mobilise as soon as clinically permitted; early physical movement promotes lung re-expansion, clears secretions, lowers postoperative pneumonia risks, and preserves muscle strength.
-
Cease smoking immediately: Complete smoking cessation and avoidance of second-hand smoke are non-negotiable to facilitate airway healing, enhance oxygen uptake, and prevent secondary recurrences.
-
Balance rest with activity: Avoid strenuous physical overexertion while engaging in gentle deep-breathing exercises, and maintain emotional well-being throughout rehabilitation.
Alternative and Complementary Treatments Beyond Lung Cancer Surgery
Depending on cancer type, molecular profiling, and the extent of spread, systemic and locoregional therapies can be used alone or alongside surgical resection.
Frequently Asked Questions (FAQ)
Will lung cancer surgery permanently affect my lung function?
Because lung tissue does not regenerate, surgical removal of a lobe or segment will result in an initial reduction in measurable lung volume. Additionally, post-surgical bed rest may lead to accumulation of bronchial secretions, which can cause transient breathlessness or pneumonia if not cleared effectively. However, with chest physiotherapy, early mobilisation, and pulmonary rehabilitation exercises, the remaining lung tissue expands and adapts over time to restore everyday functional breathing capacity.
Can lung cancer surgery be done using minimally invasive techniques, and how long is the hospital stay?
Yes, the majority of early-stage lung cancer operations in Hong Kong are now conducted via minimally invasive Video-Assisted Thoracoscopic Surgery (VATS) or Robotic-Assisted Thoracic Surgery (RATS). For uncomplicated minimally invasive procedures, the hospital stay typically ranges between 5 and 7 days, substantially shorter than the prolonged inpatient recovery needed for open thoracotomy.
Who is generally not suitable for primary lung cancer surgery?
Patients diagnosed with extensive small cell lung cancer (SCLC), advanced Stage 3B or Stage 4 non-small cell lung cancer with distant metastasis, or those with severe underlying heart failure, chronic obstructive pulmonary disease (COPD), or inadequate baseline pulmonary reserve are generally not suitable candidates for primary radical surgery. In such cases, systemic therapies such as chemotherapy, immunotherapy, or targeted therapy take precedence.
What is the main difference between a lobectomy and a wedge resection?
A lobectomy involves the complete anatomical resection of an entire lung lobe along with regional lymph node dissection, representing the standard curative surgical approach for early-stage lung cancer. A wedge resection is a tissue-sparing, sublobar procedure that excises only a small, non-anatomical wedge of tissue surrounding the tumour; it is typically reserved for very early, peripheral nodules under 2 to 3 cm or patients whose impaired cardiopulmonary function precludes lobectomy.
Related Articles
Other Topics
Blood HealthBowtie StoryBusinessCancerChinese MedicineCovidCustomer ReviewDeathcareDental HealthDigestive HealthDoctor SpecialistsDrugsEar, nose, and throatEndocrinology & DiabetesExercisingEye HealthFinanceFood & NutritionGroup Medical InsuranceHealthHealth GlossaryHeart HealthHospitalsHot TopicsImmigrationInsurance TipsKidney HealthKids HealthlearnLiver DiseaseLung & RespiratoryMedical Check UpsMen’s HealthMental HealthNervous SystemOrthopedicsOutpatient ServicesParentingPhysiotherapyPress ReleasePrevention/VaccinationProduct PhilosophyRealtyRheumatic DiseaseSeniors HealthSkin IssueSymptomsTax FilingTreatment PlanUrologyWomen’s Health女性健康